Citadel Advisors’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-67,631
| Closed | -$361K | – | 15754 |
|
|
2023
Q4 | $361K | Sell |
67,631
-3,206
| -5% | -$19.8K | ﹤0.01% | 8772 |
|
|
2023
Q3 | $567K | Hold |
70,837
| – | – | ﹤0.01% | 7793 |
|
|
2023
Q2 | $301K | Sell |
70,837
-219
| -0.3% | -$1.24K | ﹤0.01% | 9040 |
|
|
2023
Q1 | $400K | Sell |
71,056
-103
| -0.1% | -$783 | ﹤0.01% | 8770 |
|
|
2022
Q4 | $591K | Buy |
71,159
+287
| +0.4% | +$5.62K | ﹤0.01% | 7889 |
|
|
2022
Q3 | $2.28M | Sell |
70,872
-18,194
| -20% | -$675K | ﹤0.01% | 5336 |
|
|
2022
Q2 | $3.58M | Buy |
89,066
+17,658
| +25% | +$1.29M | ﹤0.01% | 4440 |
|
|
2022
Q1 | $7.64M | Buy |
71,408
+234
| +0.3% | +$36.7K | ﹤0.01% | 3402 |
|
|
2021
Q4 | $17.7M | Buy |
71,174
+49,265
| +225% | +$10.9M | ﹤0.01% | 2175 |
|
|
2021
Q3 | $4.09M | Buy |
21,909
+509
| +2% | +$102K | ﹤0.01% | 4693 |
|
|
2021
Q2 | $4.02M | Buy |
21,400
+44
| +0.2% | +$8.94K | ﹤0.01% | 4924 |
|
|
2021
Q1 | $4.33M | Hold |
21,356
| – | – | ﹤0.01% | 4588 |
|
|
2020
Q4 | $4.54M | Buy |
+21,356
| New | +$4.44M | ﹤0.01% | 3858 |
|
Citadel Advisors's SNCE Position: Q1 2024 in Review
Citadel Advisors sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 67,631 shares — an estimated $361K sold.
Citadel Advisors first reported a position in SNCE in Q4 2020 and held it in 13 quarters. The position peaked at $17.7M in Q4 2021. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.
- Citadel Advisors reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Citadel Advisors sold 67,631 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $361K.
- Citadel Advisors first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2020 and held it in 13 quarters.
- Citadel Advisors's Science 37 Holdings, Inc. Common Stock position peaked at $17.7M in Q4 2021.
- 0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.